Ferrous Sulfate Tablets 50mg

Ferrous Sulfate Tablets 50mg: What the Published Guidance Says

Our largest functional group by product count — from the individual vitamins and minerals carried on the WHO Model List through to parenteral nutrition components and finished multivitamin presentations.

Buyers usually settle three things before ordering Ferrous Sulfate Tablets 50mg: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.

• Anaemia prevention is a listed intervention Ferrous salt with folic acid appears on the Model List as an antianaemia medicine, in tablet form. Folic acid and iron are the standard pair used in national supplementation programmes, and matching your market's programme strength matters. WHO — Essential medicines (fact sheet)
• The Model List sections that carry this portfolio Vitamins and minerals sit in section 27 of the 24th WHO Model List (2025). The listings include ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol, alongside calcium and other minerals. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
• Presentation matters as much as molecule An essential medicine is meant to be provided in an appropriate dosage form for the intended use and patient. A clinic that stocks the right molecule in an inappropriate presentation has met availability and missed usability — which is why we supply chewables, effervescents, drops, syrups and injectables across the same active ingredients. WHO — Essential medicines (fact sheet)

These points are quoted because they shape how Ferrous Sulfate Tablets 50mg is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

How Ferrous Sulfate Tablets 50mg Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Ferrous Sulfate Tablets 50mg is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)
• Testing for heavy metals and elemental impurities
• Testing for packaging integrity and seal testing
• Testing for description and identification
• Testing for assay of the active substance

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How Ferrous Sulfate Tablets 50mg Is Packed, Labelled and Shipped

• Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 100 tablets per bottle. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
• Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
• Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
• Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for Ferrous Sulfate Tablets 50mg

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

• Batch manufacturing and packaging records released for inspection on request during supplier audits.
• Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
• CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
• Site Master File and GMP certificate for the manufacturing workshops.
• Method validation, stability protocol and the shelf-life justification for the marketed pack.

This page describes Ferrous Sulfate Tablets 50mg as a product of the vitamins, minerals and clinical nutrition products named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.